A new biomarker that can detect babies more at risk of Sudden Infant Death Syndrome (SIDS) while they are alive has been discovered by researchers.
A new biomarker that can detect babies more at risk of Sudden Infant Death Syndrome (SIDS) while they are alive has been discovered by researchers. The incidence of SIDS has been more than halved in recent years due to public health campaigns addressing the known major risk factors of prone sleeping, maternal smoking and overheating. However, the rate of SIDS remains high, contributing to almost 50 percent of all post-neonatal deaths in Western countries.
‘Sudden Infant Death Syndrome (SIDS) is the unexplained death of an apparently healthy infant less than one year of age, during a period of sleep.’
A team at the Children’s Hospital at Westmead (CHW) identified Butyrylcholinesterase (BChE) as the biochemical marker that can help prevent death in infants. In the study, published in The Lancets eBioMedicine, the team analyzed BChE activity in 722 Dried Blood Spots (DBS) taken at birth as part of the Newborn Screening Programme.
BChE was measured in both SIDS and infants dying from other causes, and each was compared to 10 surviving infants with the same date of birth and gender.
Sudden Infant Death Syndrome: New Findings
"The findings showed BChE levels were significantly lower in babies who subsequently died of SIDS compared to living controls and other infant deaths," said lead author Dr. Carmel Harrington, research student at CHW, who lost her child to SIDS 29 years ago.BChE plays a major role in the brain’s arousal pathway and researchers believe its deficiency likely indicates an arousal deficit, which reduces an infant’s ability to wake or respond to the external environment, causing vulnerability to SIDS.
"Babies have a very powerful mechanism to let us know when they are not happy. Usually, if a baby is confronted with a life-threatening situation, such as difficulty breathing during sleep because they are on their tummies, they will arouse and cry out. What this research shows is that some babies don’t have this same robust arousal response," Dr. Harrington added.
Advertisement
After losing her son, Damien, to SIDS, Dr. Harrington has dedicated her career to finding answers for the condition. Harrington said these results offer hope for the future and answers for the past.
Advertisement
The next step for researchers is to begin looking at introducing the BChE biomarker into newborn screening and developing specific interventions to address the enzyme deficiency.
Source-IANS